Oracle Investment Management as of Sept. 30, 2012
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 28 positions in its portfolio as reported in the September 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Onyx Pharmaceuticals | 13.1 | $76B | 896k | 84500.00 | |
| Tenet Healthcare Corporation | 12.5 | $73B | 12M | 6270.00 | |
| Quidel Corporation | 10.8 | $62B | 3.3M | 18930.00 | |
| Thoratec Corporation | 9.2 | $53B | 1.5M | 34600.00 | |
| Acorda Therapeutics | 8.9 | $52B | 2.0M | 25610.00 | |
| Elan Corporation | 5.5 | $32B | 3.0M | 10720.00 | |
| Vivus | 4.2 | $25B | 1.4M | 17810.00 | |
| Accuray Incorporated (ARAY) | 4.1 | $24B | 3.4M | 7080.00 | |
| Opko Health (OPK) | 3.6 | $21B | 5.1M | 4180.00 | |
| MAKO Surgical | 3.4 | $20B | 1.1M | 17410.00 | |
| GTx | 3.2 | $19B | 4.0M | 4580.00 | |
| MAP Pharmaceuticals | 3.2 | $18B | 1.2M | 15570.00 | |
| Gentiva Health Services | 2.5 | $15B | 1.3M | 11318.40 | |
| Hansen Medical | 2.4 | $14B | 7.1M | 1940.00 | |
| Accelr8 Technology Corporation | 2.1 | $13B | 2.2M | 5794.77 | |
| NxStage Medical | 1.9 | $11B | 816k | 13210.00 | |
| Achillion Pharmaceuticals | 1.8 | $10B | 1.0M | 10405.00 | |
| Ironwood Pharmaceuticals (IRWD) | 1.7 | $10B | 782k | 12780.00 | |
| Tesaro | 1.6 | $9.3B | 660k | 14130.48 | |
| Transition Therapeutics | 1.4 | $7.8B | 3.6M | 2190.00 | |
| Dex (DXCM) | 0.9 | $5.3B | 354k | 15030.00 | |
| WebMD Health | 0.5 | $3.1B | 222k | 14030.00 | |
| Health Net | 0.4 | $2.3B | 100k | 22510.00 | |
| Metabolix | 0.4 | $2.1B | 1.3M | 1680.00 | |
| Biogen Idec (BIIB) | 0.3 | $1.9B | 13k | 149209.99 | |
| Vanguard Health Systems | 0.2 | $1.0B | 83k | 12370.00 | |
| InterMune | 0.1 | $448M | 50k | 8960.00 | |
| Ladenburg Thalmann Financial Services | 0.1 | $264M | 200k | 1320.00 |
